Karel Bakker, Heemstede, The Netherlands, chair of the International Working Group
on the Diabetic Foot (IWGDF) and of the International Diabetes Federation’s Diabetic
Foot Programme shares the importance of the 2011 Practical and Specific Guidelines on
the Management and Prevention of the Diabetic Foot.
An important discussion ensued at the session titled “Strategic plan for interventional
radiology” at the CIRSE annual meeting in Munich, Germany, on 10 September. The
question, “Should interventional radiologists get the necessary training to be completely
in-charge of patients, including having ownership of beds and wards?” generated
interesting debate and differing points of view.
David Rosenthal, clinical professor of Surgery at the Medical College of Georgia, and
chief of Vascular Surgery, Atlanta Medical Center, Atlanta, USA, presented data on a
novel, bioconvertible vena cava filter at the VEITHsymposium in New York.
Advances in Yttrium-90 (Y-90) radioembolization for liver cancer, a leading cause of
cancer deaths worldwide, are reported in studies in the October Journal of Vascular and
Interventional Radiology (JVIR).
Registration Open Now
Register online now for the third European Conference on Interventional Oncology, held April 25 - 28, 2012 in Florence, Italy. A presto a Firenze!
Last chance to sign up for the intermediate course on hepatic interventions in Porto, October 28-29, 2011. Don’t miss it!
Drainage, Biopsies and Venous Access
This fundamental ESIR course will be held in Dublin, November 4 - 5, 2011. Register now!
Advanced Techniques in Peripheral Vascular Interventions
Only a few places are left for CIRSE Members on this challenging Institute Hands-on course. Receive training in techniques for peripheral vascular interventions in Hamburg, November 8 - 9, 2011.
Radiation Protection Workshop
On April 21 - 23, 2012 the European Workshop on Education and Training in Medical Radiation Protection will be held in Athens. Participation is free of charge. Follow the link for more information on this pan-European event.
On 21 December, TriReme announced that it has received 510(K) clearance from the
US Food and Drug Administration to market its Chocolate percutaneous transluminal
angioplasty (PTA) balloon catheter (“Chocolate”) for the treatment of occluded
peripheral arteries. Chocolate was developed in collaboration with TriReme’s
subsidiary Quattro Vascular in Singapore.
CIRSE FOUNDATION EDUCATION GRANTS
COOK MEDICAL GRANTS
Stranica 6 od 13